Eupraxia Pharmaceuticals Inc
(EPRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 6,883 | 8,264 | 7,124 | 7,482 | 6,273 |
| Operating Income | -6,883 | -8,264 | -7,124 | -7,482 | -6,273 |
| Interest Expense | 0 | 0 | 0 | 0 | 1 |
| Other Income | 513 | -478 | 360 | -49 | 282 |
| Pre-tax Income | -6,370 | -8,742 | -6,765 | -7,531 | -5,991 |
| Income Tax | -1 | -6 | 3 | -8 | N/A |
| Net Income Continuous | -6,369 | -8,737 | -6,767 | -7,522 | -5,991 |
| Minority Interests | -8 | -7 | -5 | -23 | -48 |
| Net Income | $-6,361 | $-8,741 | $-6,763 | $-7,509 | $-5,943 |
| EPS Basic Total Ops | -0.19 | -0.26 | -0.21 | -0.21 | -0.17 |
| EPS Basic Continuous Ops | -0.17 | -0.24 | -0.19 | -0.21 | -0.17 |
| EPS Diluted Total Ops | -0.19 | -0.26 | -0.21 | -0.21 | -0.17 |
| EPS Diluted Continuous Ops | -0.17 | -0.24 | -0.19 | -0.21 | -0.17 |
| EPS Diluted Before Non-Recurring Items | -0.19 | -0.26 | -0.21 | -0.21 | -0.17 |
| EBITDA(a) | $-6,820 | $-8,209 | $-7,078 | $-7,427 | $-6,236 |